<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
Contains fulltext : 87773.pdf (publisher's version ) (Closed access)In patients wi...
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
Background: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in p...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in patients with...
Copyright: 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of ...
Stroke remains a common and costly problem world-wide, but substantial advances have been made in re...
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
Contains fulltext : 87773.pdf (publisher's version ) (Closed access)In patients wi...
<p>Comparison of new oral anticoagulants versus imputed placebo on the risk of stroke.</p
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
<p>Imputed placebo analysis. Comparison of new oral anticoagulants versus imputed placebo on the ris...
Background: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in p...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
<div><p>Background</p><p>Edoxaban recently proved non-inferior to warfarin for prevention of thrombo...
<p>Studies are grouped by type of anticoagulant. Weight is the relative contribution of each study t...
Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in patients with...
Copyright: 2014 The PLOS ONE Staff. This is an open-access article distributed under the terms of ...
Stroke remains a common and costly problem world-wide, but substantial advances have been made in re...
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Estimated proportion of warfarin benefit by new oral anticoagulants on the risk of stroke.</p
<p>Meta-analysis of all trials comparing clopidogrel plus aspirin with aspirin plus placebo or aspir...
Contains fulltext : 87773.pdf (publisher's version ) (Closed access)In patients wi...
DOI
Add to ORKG